• 1
    Greene P, Kang U, Fahn S, Brin M, Moskowitz C, Flaster E. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology. 1990;40:1213-1218.
  • 2
    Jankovic J & Orman J. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology. 1987;37:616-623.
  • 3
    Simpson DM, Alexander DN, O'brien CF, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology. 1996;46:1306-1310.
  • 4
    Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB. Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol. 1990;28:512-515.
  • 5
    Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A. A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med. 1998;338:217-220.
  • 6
    Annese V, Basciani M, Borrelli O, Leandro G, Simone P, Andriulli A. Intrasphincteric injection of botulinum toxin is effective in long-term treatment of esophageal achalasia. Muscle Nerve. 1998;21:1540-1542.
  • 7
    Naumann M, Flachenecker P, Brocker EB, Toyka KV, Reiners K. Botulinum toxin for palmar hyperhidrosis. Lancet. 1997;349:252.
  • 8
    Knusel B, Grant M, Loesser JD, et al.Intramuscular injection of botulinum toxin type A (BOTOX®) in chronic low back pain associated with muscle spasm. Poster presented at: American Pain Society Meeting; November 1998; San Diego, Calif. Poster 672.
  • 9
    Binder W, Brin MF, Blitzer A, Schenrock L, Diamond B. Botulinum toxin type A (BTX-A) for migraine: an open label assessment [abstract]. Mov Disord. 1998;13(suppl 2):241(P4-104)
  • 10
    Davidoff RA. Migraine: Manifestations, Pathogenesis, and Management. Philadelphia, Pa: FA Davis Co; 1995.
  • 11
    Borodic GE, Ferrante RJ, Pearce LB, Alderson K. Pharmacology and histology of the therapeutic application of botulinum toxin. In: JankovicJ, HallettM, eds. Therapy With Botulinum Toxin. New York, NY: Marcel and Dekker, Inc; 1994:119-158.
  • 12
    Tfelt-Hansen P, Lous I, Olesen J. Prevalence and significance of muscle tenderness during common migraine attacks. Headache. 1981;21:49-54.
  • 13
    Hohne-Zell B, Galler A, Schepp W, Gratzl M, Prinz C. Functional importance of synaptobrevin and SNAP-25 during exocytosis of histamine by rat gastric enterochromaffin-like cells. Endocrinology. 1997; 138:5518-5526.